(Alliance News) - GSK PLC on Monday announced a change in leadership, after its Chief Financial Officer Iain Mackay decided to retire.
The Brentford, west London-based pharmaceuticals firm has named Burberry Group PLC's Julie Brown as his successor. Brown is currently chief operating and financial officer at the luxury fashion retailer. She has been with the firm since 2016.
Brown will join in April of next year to work on transitioning responsibilities with Mackay, who will step down in May.
Brown previously worked at AstraZeneca PLC and Smith & Nephew PLC, as well as serving as a non-executive director and audit chair of Roche Holding AG.
"I am absolutely delighted that Julie will be joining the leadership team as his successor. Julie is a highly experienced CFO with a tremendous understanding of the biopharma sector," commented Chief Executive Officer Emma Walmsley.
Shares in GSK were 1.1% higher at 1,328.00 pence each in London on Monday morning.
Burberry had said on Friday that the process to identify a successor has begun, and it will update further in due course.
Brown will leave Burberry at the close of its current financial year on April 1, 2023.
By Elizabeth Winter; elizabethwinter@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
Glaxosmithkline (GSK)
Burberry (BRBY)
Smith & Nephew (SN.)
Astrazeneca (AZN)
